Figure 2

Proportions of patients developing herpes zoster after cancer diagnosis. The proportions of patients developing HZ by time since index date are plotted. Cancer patients in this analysis were required to have survived for at least 2 years after cancer diagnosis. The proportion of patients being diagnosed with HZ was plotted for the overall, hematologic, solid tumor, and non-cancer cohorts. Dashed lines indicate the percentage of each cohort with HZ at 1 year since the index date. Approximately 3.75% and 1.50% of patients in the hematologic and solid cancer cohorts developed HZ within 1 year of cancer diagnosis, compared with 1.10% of non-cancer patients. The proportions of hematologic and solid cancer patients who developed HZ within 2 years of cancer diagnosis were 6.6% and 3.0%, respectively.